Avanos Medical (AVNS)
(Delayed Data from NYSE)
$18.62 USD
+0.52 (2.87%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $18.63 +0.01 (0.05%) 6:22 PM ET
4-Sell of 5 4
B Value D Growth A Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AVNS 18.62 +0.52(2.87%)
Will AVNS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for AVNS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVNS
Three Reasons to Retain Avanos (AVNS) Stock in Your Portfolio
Why Is Integra (IART) Down 4% Since Last Earnings Report?
AVNS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Avanos (AVNS) Q4 Earnings Lag Estimates, Margins Contract
New Strong Sell Stocks for January 16th
New Strong Sell Stocks for January 12th
Other News for AVNS
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2024 Financial Results
Commit To Buy Avanos Medical At $10, Earn 57% Annualized Using Options
What's Driving Establishment Labs Holdings Inc's Surprising 93% Stock Rally?
Atrion Corporation Is Overvalued For The Direction Fundamentals Are Heading
Avanos Medical Inc's SVP - CFO Michael Greiner Sells 8,000 Shares